Advertisement
Screener

BULLFROG AI HOLDINGS, INC. (BFRG) Increase (Decrease) in Accounts Payable

2.8 / 5 stars · 68/120 Roast Me

BULLFROG AI HOLDINGS, INC. Increase (Decrease) in Accounts Payable

BULLFROG AI HOLDINGS, INC. (BFRG) reported Increase (Decrease) in Accounts Payable of $1.79 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-14

  • BULLFROG AI HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$47.04K.
  • BULLFROG AI HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $48.84K.
  • BULLFROG AI HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was -$61.00, a 100.02% decline year-over-year.
  • BULLFROG AI HOLDINGS, INC. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$13.58K, a 245.13% decline year-over-year.
  • BULLFROG AI HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2025 was -$267.78K, a 180.59% decline from fiscal 2024.
  • BULLFROG AI HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2024 was $332.28K.
  • BULLFROG AI HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2023 was -$440.34K, a 192.62% decline from fiscal 2022.
  • BULLFROG AI HOLDINGS, INC. increase (decrease) in accounts payable for fiscal 2022 was $475.40K.
Period endIncrease (Decrease) in Accounts Payable 3 monthIncrease (Decrease) in Accounts Payable 6 monthIncrease (Decrease) in Accounts Payable 9 monthIncrease (Decrease) in Accounts Payable 12 month
2026-06-30-$47.04K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
$1.79K
10-Q · filed 2026-08-14
$1.73K
derived: sum of 3 quarters · filed 2026-08-14
-$11.85K
derived: sum of 4 quarters · filed 2026-08-14
2026-03-31$48.84K
10-Q · filed 2026-05-14
$48.77K
derived: sum of 2 quarters · filed 2026-05-14
$35.19K
derived: sum of 3 quarters · filed 2026-05-14
$6.45K
derived: sum of 4 quarters · filed 2026-08-14
2025-12-31-$61.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
-$13.64K
derived: sum of 2 quarters · filed 2026-03-19
-$42.38K
derived: sum of 3 quarters · filed 2026-08-14
-$267.78K
10-K · filed 2026-03-19
2025-09-30-$13.58K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$42.32K
derived: sum of 2 quarters · filed 2026-08-14
-$267.72K
10-Q · filed 2025-11-14
$76.84K
derived: sum of 4 quarters · filed 2026-08-14
2025-06-30-$28.74K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14
-$254.14K
10-Q · filed 2026-08-14
$90.42K
derived: sum of 3 quarters · filed 2026-08-14
$99.78K
derived: sum of 4 quarters · filed 2026-08-14
2025-03-31-$225.40K
10-Q · filed 2026-05-14
$119.16K
derived: sum of 2 quarters · filed 2026-05-14
$128.52K
derived: sum of 3 quarters · filed 2026-05-14
$55.99K
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31$344.56K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
$353.92K
derived: sum of 2 quarters · filed 2026-03-19
$281.39K
derived: sum of 3 quarters · filed 2026-03-19
$332.28K
10-K · filed 2026-03-19
2024-09-30$9.36K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14
-$63.17K
derived: sum of 2 quarters · filed 2025-11-14
-$12.28K
10-Q · filed 2025-11-14
-$19.13K
derived: sum of 4 quarters · filed 2025-11-14
2024-06-30-$72.53K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13
-$21.64K
10-Q · filed 2025-08-13
-$28.49K
derived: sum of 3 quarters · filed 2025-08-13
-$408.70K
derived: sum of 4 quarters · filed 2025-08-13
2024-03-31$50.89K
10-Q · filed 2025-05-13
$44.04K
derived: sum of 2 quarters · filed 2025-05-13
-$336.17K
derived: sum of 3 quarters · filed 2025-05-13
-$482.35K
derived: sum of 4 quarters · filed 2025-05-13
2023-12-31-$6.85K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14
-$387.06K
derived: sum of 2 quarters · filed 2025-03-14
-$533.24K
derived: sum of 3 quarters · filed 2025-03-14
-$440.34K
10-K · filed 2025-03-14
2023-09-30-$380.21K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08
-$526.39K
derived: sum of 2 quarters · filed 2024-11-08
-$433.49K
10-Q · filed 2024-11-08
-$10.04K
derived: sum of 4 quarters · filed 2024-11-08
2023-06-30-$146.18K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
-$53.28K
10-Q · filed 2024-08-07
$370.17K
derived: sum of 3 quarters · filed 2024-08-07
$389.44K
derived: sum of 4 quarters · filed 2024-08-07
2023-03-31$92.90K
10-Q · filed 2024-05-10
$516.35K
derived: sum of 2 quarters · filed 2024-05-10
$535.62K
derived: sum of 3 quarters · filed 2024-05-10
$482.75K
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$423.45K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29
$442.72K
derived: sum of 2 quarters · filed 2024-03-29
$389.86K
derived: sum of 3 quarters · filed 2024-03-29
$475.40K
10-K · filed 2024-03-29
2022-09-30$19.27K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$33.60K
derived: sum of 2 quarters · filed 2023-11-14
$51.95K
10-Q · filed 2023-11-14
2022-06-30-$52.87K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14
$32.68K
10-Q · filed 2023-08-14
2022-03-31$85.54K
10-Q · filed 2023-05-24
2021-12-31-$25.85K
10-K · filed 2023-04-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
ACTUATE THERAPEUTICS, INC. (ACTU)United States$0.015B
Vistagen Therapeutics, Inc. (VTGN)United States$0.013B-0.14
MUSTANG BIO, INC. (MBIO)United States$0.013B
Anebulo Pharmaceuticals, Inc. (ANEB)United States$0.015B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Lantern Pharma Inc. (LTRN)United States$0.015B-2.87
Tempest Therapeutics, Inc. (TPST)United States$0.013B